Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
Selagine and Grifols Team Up for DED Eye Drops
Selagine announced a global collaboration with Grifols to develop and commercialize immunoglobulin eye drops for dry eye disease. Financial terms of the agreement were not disclosed. As per the agreement, Selagine will receive an upfront payment and annual collaboration fee,…
Apotex Recalls Brimonidine Tartrate Ophthalmic Solution
Apotex Corp. has initiated a voluntary recall at the consumer level for 6 lots of brimonidine tartrate ophthalmic solution, 0.15%, distributed nationwide in the United States between April 5, 2022 to February 22, 2023 with the guidance of the US…
Akorn Pharmaceuticals Files for Bankruptcy
Akorn Pharmaceuticals, a maker of generic and branded drugs, has announced that it is ceasing operations business. The company, which provided over 20 ophthalmic products, has filed for chapter 7 bankruptcy, and will close all facilities in the United States. In…
3D-printed Smart Contact Lens with Navigation Function
Dr. Seol Seung-Kwon’s research team on Smart 3D Printing at KERI, in collaboration with Professor Lim-Doo Jeong’s team at Ulsan National Institute of Science and Technology (UNIST), have jointly developed a new core technology for smart contact lenses. The lenses…
M1 Molecule: A Promising Treatment for Optic Nerve Injury
Traumatic injury to the central nervous system (CNS), spinal cord, and optic nerve is the primary cause of disability and the second largest cause of mortality worldwide. CNS injuries frequently result in catastrophic loss of sensory, motor, and visual skills,…
HealthCare Royalty And Clearside Bio to Enter Into Agreement
Clearside Biomedical announced it has entered into an agreement with HealthCare Royalty Partners in a deal worth up to $65 million. The money received from the deal will be put to use by Clearside to fund the ongoing clinical testing…
Noninferiority randomised trials in ophthalmology – Eye – Nature
Noninferiority randomised trials in ophthalmology – Eye Nature Source: Author: | Date: 2023-03-03 08:00:00 Source: Author: | Date: 2023-03-03 08:00:00
Topcon and OphtAI Collaborate for AI Technology
Topcon Healthcare Solutions and OphtAI, a joint venture specialized in Artificial Intelligence (AI) for ophthalmology, have announced a partnership to integrate OphtAI into Topcon’s Harmony Referral System, and provide eye care professionals with smarter access to AI services. OphtAI’s state-of-the-art…
Fungal Endophthalmitis Outbreak in South Korea
South Korean ophthalmologists reported a fungal endophthalmitis outbreak after cataract surgery due to contaminated viscoelastic material. Researchers from the Department of Ophthalmology at Korea University Guro Hospital in Seoul, Korea, under the direction of Seong Woo Kim, MD, PhD, found…
ELITA Femtosecond Laser System Receives CE Mark
Johnson & Johnson Vision has announced that they have received CE Mark approval for the ELITA Femtosecond Laser System. The laser is designed to perform refractive correction on patients with myopia, with or without astigmatism, using the SILK (Smooth Incision…